Active ingredientPyridostigmine BromideCat. No. P-P238-001CAS 101-26-8Family · Pharmaceutical analytical standards
Pyridostigmine
An acetylcholinesterase inhibitor patented in 1945 and in medical use since 1955, used mainly for the muscle weakness of myasthenia gravis and sometimes also for orthostatic hypotension. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Like its predecessor neostigmine it is a carbamate with a permanently charged nitrogen, which stops it crossing the blood-brain barrier; it is on the WHO List of Essential Medicines.
Go to the active ingredient →Active ingredientPyridostigmine BromideCat. No. P-P238-001CAS 101-26-8
Pharmacopoeial impurityPyridostigmine EP Impurity BCat. No. P-P238-002CAS 4685-07-8
Pharmacopoeial impurityPyridostigmine Bromide EP Impurity ACat. No. P-P238-003CAS 51581-32-9
Pharmacopoeial impurityPyridostigmine Bromide EP Impurity BCat. No. P-P238-004CAS 31034-86-3
Isotopically labelledPyridostigmine-d3 BromideCat. No. P-P238-005CAS 1633751-00-4
Isotopically labelledPyridostigmine-d6 BromideCat. No. P-P238-006CAS 2375858-08-3
Impurity3-Hydroxy-1-methyl-pyridinium IodideCat. No. P-P238-007CAS 7500-05-2
Impurity3-HydroxypyridineCat. No. P-P238-008CAS 109-00-2No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substancePyridostigmine bromide CRSEDQM code P4099900Family PyridostigmineImpurityPyridostigmine impurity A CRSEDQM code P4099910Family PyridostigmineImpurityPyridostigmine impurity B CRSEDQM code Y0001486Family PyridostigmineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.